<SEC-DOCUMENT>0000921895-17-001972.txt : 20170724
<SEC-HEADER>0000921895-17-001972.hdr.sgml : 20170724
<ACCEPTANCE-DATETIME>20170724170958
ACCESSION NUMBER:		0000921895-17-001972
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20170724
DATE AS OF CHANGE:		20170724

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Capstone Therapeutics Corp.
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-42745
		FILM NUMBER:		17978819

	BUSINESS ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		STREET 2:		SUITE 101
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
		BUSINESS PHONE:		6022865520

	MAIL ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		STREET 2:		SUITE 101
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHOLOGIC CORP
		DATE OF NAME CHANGE:	19940211

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BP Peptides, LLC
		CENTRAL INDEX KEY:			0001711689
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		122 EAST 42ND STREET
		STREET 2:		SUITE 4305
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10168
		BUSINESS PHONE:		212-302-0699

	MAIL ADDRESS:	
		STREET 1:		122 EAST 42ND STREET
		STREET 2:		SUITE 4305
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10168
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<FILENAME>sc13d10959006_07242017.htm
<DESCRIPTION>SCHEDULE 13D
<TEXT>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="margin: 0"></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><b>UNITED STATES</b></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><b>Washington, D.C. 20549</b></p>

<p></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><b>SCHEDULE 13D</b></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(Rule 13d-101)</p>

<p></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">INFORMATION TO BE INCLUDED
IN STATEMENTS FILED PURSUANT</p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">TO &#167;&#160;240.13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO</p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">&#167;&#160;240.13d-2(a)</p>

<p></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(Amendment No.&#160; )<FONT STYLE="font-size: 8pt"><SUP>1</SUP></FONT></p>

<p></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><font style="font-weight: normal"><u></U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Capstone Therapeutics Corp.</U></P>



<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal"><U></u></font></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(Name
of Issuer)</p>

<p></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><font style="font-weight: normal"><u></U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>Common Stock, $0.0005 par value</U></P>



<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal"><U></u></font></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(Title of Class of Securities)</p>

<p></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><u>14068E109</u></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(CUSIP Number)</p>

<p style="text-indent: 0pt; margin-right: 0; margin-left: 0"></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><font style="font-weight: normal"></U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Jeffrey S. Spindler, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Olshan Frome Wolosky <FONT STYLE="text-transform: uppercase">LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">1325 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><U>(212)
451-2300</U></FONT></P>



<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal"><U></u></font></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(Name, Address and Telephone Number of Person</p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">Authorized to Receive Notices
and Communications)</p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal"><U></U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><U>July 14, 2017</U></P>



<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-weight: normal"><U></U></FONT></p>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">(Date of Event Which Requires
Filing of This Statement)</P>

<P STYLE="text-align: center; display: block; margin-top: 0; margin-bottom: 0">&nbsp;</p>

<P STYLE="text-indent: 36pt; margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule
13D, and is filing this schedule because of &#167;&#167;&#160;240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box </FONT><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT></p>

<P STYLE="text-indent: 36pt; margin-right: 0; margin-left: 0; font: 10pt Times New Roman, Times, Serif"><i>Note:</i>&#160;&#160;Schedules
filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.&#160;&#160;<i>See
</i>&#167;&#160;240.13d-7 for other parties to whom copies are to be sent.</P>

<P STYLE="text-align: left; display: block; margin-top: 0; margin-bottom: 0">&nbsp;</p>
<P STYLE="text-align: left; display: block; margin-top: 0; margin-bottom: 0">&nbsp;</p>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 6pt"><FONT STYLE="font-size: 7pt">1</FONT>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.</p>

<p style="text-indent: 36pt; margin-right: 0; margin-left: 0; font: 10pt Times New Roman, Times, Serif">The information required
on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities
Exchange Act of 1934 (&#8220;Act&#8221;) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, <I>see</I> the <I>Notes</I>).</p>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; border-left: Black 1pt solid; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: middle"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%"></TD>
    <TD STYLE="width: 5%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-top: black 2.25pt double; border-left: black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 2.25pt double; text-align: center; vertical-align: top">1</TD>
    <TD STYLE="border-top: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 2.25pt double; border-left: Black 1pt solid; padding-left: 6pt">NAME OF REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	BP Peptides, LLC</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">2</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">(a)&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">(b) &#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">3</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">SEC USE ONLY</TD>
    <TD STYLE="border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle"></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">4</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">SOURCE OF FUNDS</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	WC</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">5</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 2.25pt double">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt"></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">6</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CITIZENSHIP OR PLACE OF ORGANIZATION</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	Delaware</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">NUMBER OF</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">7</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SOLE VOTING POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">SHARES</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">BENEFICIALLY</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">OWNED BY</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">8</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SHARED VOTING POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">EACH</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">REPORTING</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	18,541,197</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">PERSON WITH</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">9</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SOLE DISPOSITIVE POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top"> </TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">10</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SHARED DISPOSITIVE POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	18,541,197</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">11</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	18,541,197</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">12</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 2.25pt double">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid"></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">13</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	34.1%</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">14</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">TYPE OF REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-bottom: Black 2.25pt double; text-align: left; vertical-align: middle">OO</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-bottom: Black 2.25pt double">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</p>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<p style="text-align: center"></p>

<P STYLE="margin-top: 0; margin-bottom: 0"></p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; border-left: Black 1pt solid; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: middle"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%"></TD>
    <TD STYLE="width: 5%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-top: black 2.25pt double; border-left: black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 2.25pt double; text-align: center; vertical-align: top">1</TD>
    <TD STYLE="border-top: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 2.25pt double; border-left: Black 1pt solid; padding-left: 6pt">NAME OF REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	Matthew E. Lipman</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">2</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">(a)&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">(b) &#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">3</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">SEC USE ONLY</TD>
    <TD STYLE="border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle"></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">4</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">SOURCE OF FUNDS</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	AF</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">5</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 2.25pt double">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt"></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">6</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CITIZENSHIP OR PLACE OF ORGANIZATION</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	USA</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">NUMBER OF</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">7</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SOLE VOTING POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">SHARES</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">BENEFICIALLY</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">OWNED BY</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">8</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SHARED VOTING POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">EACH</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">REPORTING</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	18,541,197</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">PERSON WITH</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">9</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SOLE DISPOSITIVE POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top"> </TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">10</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SHARED DISPOSITIVE POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	18,541,197</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">11</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	18,541,197</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">12</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 2.25pt double">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid"></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">13</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	34.1%</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">14</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">TYPE OF REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-bottom: Black 2.25pt double; text-align: left; vertical-align: middle">IN</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-bottom: Black 2.25pt double">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</p>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: top"></TD>
    <TD STYLE="width: 5%; border-left: Black 1pt solid; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; text-align: center; vertical-align: middle"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%; padding-left: 6pt"></TD>
    <TD STYLE="width: 5%"></TD>
    <TD STYLE="width: 5%"></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-top: black 2.25pt double; border-left: black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 2.25pt double; text-align: center; vertical-align: top">1</TD>
    <TD STYLE="border-top: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 2.25pt double; border-left: Black 1pt solid; padding-left: 6pt">NAME OF REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	Michael Toporek</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">2</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">(a)&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">(b) &#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">3</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">SEC USE ONLY</TD>
    <TD STYLE="border-top: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle"></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">4</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">SOURCE OF FUNDS</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle"></TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">5</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 2.25pt double">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid; padding-left: 6pt"></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">6</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CITIZENSHIP OR PLACE OF ORGANIZATION</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	USA</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">NUMBER OF</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">7</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SOLE VOTING POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">SHARES</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">BENEFICIALLY</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">OWNED BY</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">8</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SHARED VOTING POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">EACH</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">REPORTING</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">PERSON WITH</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">9</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SOLE DISPOSITIVE POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top"> </TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: middle">10</TD>
    <TD STYLE="border-right: Black 1pt solid; border-top: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="border-top: Black 1pt solid; padding-left: 6pt">SHARED DISPOSITIVE POWER</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD COLSPAN="3" STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: middle">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">11</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	- 0 -</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">12</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES</TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 2.25pt double">&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-left: Black 1pt solid"></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="text-align: left; vertical-align: middle">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">13</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="text-align: left; vertical-align: middle">	0%</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">14</TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-left: 6pt">TYPE OF REPORTING PERSON</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-top: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD STYLE="border-right: Black 2.25pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="border-left: Black 2.25pt double; border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; text-align: center; vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.25pt double; border-left: Black 1pt solid; padding-left: 6pt">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="border-bottom: Black 2.25pt double; text-align: left; vertical-align: middle">IN</TD>
    <TD STYLE="border-right: Black 2.25pt double; border-bottom: Black 2.25pt double">&nbsp;</TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</p>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The following constitutes
the Schedule 13D filed by the undersigned (the &ldquo;Schedule 13D&rdquo;).</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 1.</TD><TD><U>Security and Issuer</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">This statement relates
to the Common Stock, $0.0005 par value per share (the &ldquo;Shares&rdquo;), of Capstone Therapeutics Corp., a Delaware corporation
(the &ldquo;Issuer&rdquo;). The address of the principal executive offices of the Issuer is 1275 West Washington Street, Suite
104, Tempe, Arizona 85281.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 2.</TD><TD><U>Identity and Background</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
statement is filed by BP Peptides, LLC, a Delaware limited liability company (&ldquo;BP Peptides&rdquo;), Matthew E. Lipman and
Michael Toporek. Each of the foregoing is referred to as a &ldquo;Reporting Person&rdquo; and collectively as the &ldquo;Reporting
Persons.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Matthew E. Lipman
is the Manager and President of BP Peptides. By virtue of this relationship, Mr. Lipman may be deemed to beneficially own the Shares
directly owned by BP Peptides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
address of the principal office of each of the Reporting Persons is 122 East 42<SUP>nd</SUP> Street, Suite 4305, New York, New
York 10168.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
principal business of BP Peptides is investing in securities. The principal occupation of Matthew E. Lipman is serving as an employee
of Ambrose Employer Group, LLC, a human resources outsourcing firm. The principal occupation of Michael Toporek is serving as a
Principal of MJT Park Investors, Inc., a management and consulting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations
of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to
such laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BP
Peptides is organized under the laws of the State of Delaware. Each of Matthew E. Lipman and Michael Toporek is a citizen of the
United States of America.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 3.</TD><TD><U>Source and Amount of Funds or Other Consideration</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The aggregate purchase
price of the 18,541,197 Shares owned directly by BP Peptides is $1,314,971.82. Such Shares were acquired with the working capital
of BP Peptides.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 4.</TD><TD><U>Purpose of Transaction</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Matthew E.
Lipman and Michael Toporek have been appointed to the board of directors of the Issuer in connection with the Securities
Purchase Agreement (as defined below). Except in Messrs. Lipman&rsquo;s and Toporek&rsquo;s capacities as directors of the
Issuer, no Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth
in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein. The Reporting Persons reserve the right
to increase or decrease their respective positions in the Issuer through, among other things, the purchase or sale of
securities of the Issuer on the open market or in private transactions or otherwise, on such terms and at such times as the
Reporting Persons may deem advisable. The Reporting Persons reserve the right to change their intention with respect to any
and all matters referred to in this Item 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Reference is made
to the description of the Securities Purchase Agreement, Registration Rights Agreement, Note and BVF Agreement (each as defined
below) in Item 6. The Securities Purchase Agreement, Registration Rights Agreement, Note and BVF Agreement are either referenced
or attached as Exhibit 99.1, Exhibit 99.2, Exhibit 99.3 and Exhibit 99.4, respectively, hereto and are incorporated herein by reference.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 5.</TD><TD><U>Interest in Securities of the Issuer</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
aggregate percentage of Shares reported owned by each person named herein is based upon 54,385,411 Shares outstanding, which is
comprised of 40,885,411 Shares outstanding as disclosed in Exhibit 10.1 to the Form 8-K filed by the Issuer on July 17, 2017, plus
the 13,500,000 Shares issued to BP Peptides in connection with the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">As of the close of
business on the date hereof, BP Peptides directly owned 18,541,197 Shares, constituting approximately 34.1% of the Shares outstanding.
By virtue of his relationship with BP Peptides discussed in further detail in Item 2, Matthew E. Lipman may be deemed to beneficially
own the Shares directly owned by BP Peptides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">As of the close of
business on the date hereof, Matthew E. Lipman did not directly own any securities of the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">As of the close of
business on the date hereof, Michael Toporek did not directly own any securities of the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Each of the Reporting
Persons, as a member of a &ldquo;group&rdquo; with the other Reporting Persons for purposes of Rule 13d-5(b)(1) of the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), may be deemed to beneficially own the securities of the Issuer
owned by the other Reporting Persons. The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons
are, for purposes of Section 13(d) of the Exchange Act, the beneficial owners of any securities of the Issuer he or it does not
directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities of the Issuer reported
herein that he or it does not directly own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BP
Peptides may be deemed to share with Matthew E. Lipman the power to vote and dispose of the Shares directly owned by BP Peptides.</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There
have been no transactions in the Shares of the Issuer by the Reporting Persons during the past 60 days, except for the acquisition
by BP Peptides of 13,500,000 Shares pursuant to the Securities Purchase Agreement and 5,041,197 Shares pursuant to the BVF Agreement,
as discussed in greater detail in Item 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends
from, or proceeds from the sale of, the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not
applicable.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 6.</TD><TD><U>Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><U>Securities Purchase,
Loan and Security Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">On July 14, 2017,
the Issuer and BP Peptides entered into a Securities Purchase, Loan and Security Agreement (the &ldquo;Securities Purchase Agreement&rdquo;)
pursuant to which on such date the Issuer issued and sold 13,500,000 Shares (the &ldquo;Capstone Shares&rdquo;) to BP Peptides
for an aggregate of $1,012,500 and BP Peptides made a loan to the Issuer (the &ldquo;Loan&rdquo;) in the principal amount of $2,427,500.
The Issuer also agreed to (i) appoint Matthew E. Lipman and Michael Toporek, each a designee of BP Peptides, to the Issuer&rsquo;s
board of directors (the &ldquo;Board&rdquo;), (ii) appoint Mr. Lipman to the Audit Committee of the Board and Mr. Toporek to the
Compensation Committee of the Board, (iii) maintain such committee appointments, (iv) appoint one of such designated directors
(or a successor named by BP Peptides) to each Board committee created after July 14, 2017 and maintain such appointments, and (v)
include certain numbers of such designated directors (or successor named by BP Peptides) as nominees recommended by the Board for
election as directors, as long as BP Peptides and its affiliates beneficially own specified percentages of outstanding Shares of
the Issuer. At any time BP Peptides and its affiliates beneficially own at least 20% of the outstanding Shares of the Issuer, the
Issuer must include two such BP Peptides-designated directors on its Board and as Board-recommended director nominees. At any time
BP Peptides and its affiliates beneficially own at least 5% but less than 20% of the outstanding Shares of the Issuer, the Issuer
must include one such BP Peptides-designated director on its Board and as a Board-recommended director nominee. At any time BP
Peptides and its affiliates beneficially own less than 5% of the outstanding Shares of the Issuer, the Issuer will not be obligated
to include any BP Peptides-designated director on its Board or as a Board-recommended director nominee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The Issuer further
agreed pursuant to the Securities Purchase Agreement that it would not effect any public sale or distribution of its equity securities,
or any securities convertible into or exchangeable or exercisable for its equity securities, other than pursuant to a Demand Registration
(as defined below) during the 90-day period beginning on the effective date of any registration statement in connection with a
Demand Registration, except pursuant to a registration statement covering (i) sales or distributions of the Issuer&rsquo;s equity
securities or any securities convertible into or exchangeable or exercisable for its equity securities pursuant to a registration
statement on Form S-4 or Form S-8 or any successor form, or (ii) the issuance of Shares of the Issuer in connection with transfers
to dividend reinvestment plans or to employee benefit plans in order to enable any such employee benefit plan to fulfill its funding
obligations in the ordinary course. The Issuer also granted BP Peptides certain preemptive rights with respect to securities of
the Issuer.</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">In connection with
the Securities Purchase Agreement, the Board approved the acquisition of the Capstone Shares and the BVF Shares (as defined below)
for purposes of the Tax Benefit Preservation Plan Agreement, dated as of April 18, 2017, between the Issuer and Computershare Trust
Company, N.A., as Rights Agent (the &ldquo;Plan&rdquo;), making BP Peptides and its affiliates and associates &ldquo;Exempt Persons&rdquo;
under the Plan in respect of such transactions. The Board also approved the acquisition of the Capstone Shares and the BVF Shares
for purposes of Section 203 of the Delaware General Corporation Law and Article 11 of the Certificate of Incorporation of the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The foregoing description
of the Securities Purchase Agreement is qualified in its entirety by reference to the full text of the Securities Purchase Agreement,
which is referenced as Exhibit 99.1 hereto and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><U>Registration Rights
Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">On July 14, 2017,
the Issuer and BP Peptides entered into a Registration Rights Agreement (the &ldquo;Registration Rights Agreement&rdquo;) pursuant
to which the Issuer agreed, upon the request of holders of at least 25% of the outstanding Capstone Shares, to file a registration
statement under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), to register the resale of the Capstone
Shares (a &ldquo;Demand Registration&rdquo;). The Issuer also agreed, subject to certain conditions and exclusions, to include
the resale of the Capstone Shares in any registration statement that the Issuer files under the Securities Act (other than a registration
statement on Form S-4 or Form S-8) upon the request of any holder of Capstone Shares. The Registration Rights Agreement terminates
on the earlier of July 15, 2022 or the date that BP Peptides and any permitted assignee or successor of BP Peptides owning Capstone
Shares no longer hold collectively at least 5% of the outstanding Shares of the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The foregoing description
of the Registration Rights Agreement is qualified in its entirety by reference to the full text of the Registration Rights Agreement,
which is referenced as Exhibit 99.2 hereto and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><U>Promissory Note</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">On July 14, 2017,
the Issuer executed and delivered to BP Peptides a Promissory Note (the &ldquo;Note&rdquo;) evidencing the Loan. The Loan bears
interest at the rate of 6% per annum, payable quarterly in cash, on the outstanding principal balance of the Loan. The outstanding
principal balance of the Loan will be due and payable in full on October 15, 2020. BP Peptides has a first priority security interest
in all the assets of the Issuer to secure the Loan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The foregoing description
of the Note is qualified in its entirety by reference to the full text of the Note, which is referenced as Exhibit 99.3 hereto
and is incorporated herein by reference.</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><U>BVF Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">On July 14, 2017,
concurrently with the consummation of the transactions described above, BP Peptides and Biotechnology Value Fund, L.P., Biotechnology
Value Fund II, L.P., Investment 10, L.L.C., BVF MSI SPV, L.L.C. and BVF Investments, L.L.C. (collectively, &ldquo;BVF&rdquo;) entered
into a letter agreement (the &ldquo;BVF Agreement&rdquo;) pursuant to which BP Peptides purchased 5,041,197 Shares of the Issuer
(the &ldquo;BVF Shares&rdquo;) from BVF for an aggregate of $302,471.82. BVF also agreed to certain standstill provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The foregoing description
of the BVF Agreement is qualified in its entirety by reference to the full text of the BVF Agreement, which is filed as Exhibit
99.4 hereto and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><U>Joint Filing Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">On July 24, 2017,
the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf
of each of them of statements on Schedule 13D with respect to the securities of the Issuer. A copy of this agreement is filed as
Exhibit 99.5 hereto and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">Other than as described
herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting
Persons and any other person, with respect to the securities of the Issuer.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">Item 7.</TD><TD><U>Material to be Filed as Exhibits</U>.</TD></TR></TABLE>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%; padding-right: 5.4pt; padding-bottom: 12pt; text-indent: 0in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; padding-right: 5.4pt; padding-bottom: 12pt; text-indent: 0in; text-align: center; vertical-align: top"><FONT STYLE="font-size: 10pt"><U>Exhibit No.</U></FONT></TD>
    <TD STYLE="width: 84%; padding-right: 5.4pt; padding-bottom: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><U>Description</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Securities Purchase, Loan and Security Agreement by and between Capstone Therapeutics Corp. and BP Peptides, LLC, dated July 14, 2017 (incorporated by reference to Exhibit 10.1 to the Form 8-K filed by the Issuer on July 17, 2017).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">99.2</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Registration Rights Agreement by and between Capstone Therapeutics Corp. and BP Peptides, LLC, dated July 14, 2017 (incorporated by reference to Exhibit 10.3 to the Form 8-K filed by the Issuer on July 17, 2017).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">99.3</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Promissory Note by Capstone Therapeutics Corp., dated July 14, 2017 (incorporated by reference to Exhibit 10.2 to the Form 8-K filed by the Issuer on July 17, 2017).</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">99.4</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Letter Agreement by and among BP Peptides, LLC and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Investment 10, L.L.C., BVF MSI SPV, L.L.C. and BVF Investments, L.L.C., dated July 14, 2017.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: center; text-indent: 0in"><FONT STYLE="font-size: 10pt">99.5</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-bottom: 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt">Joint Filing Agreement by and among BP Peptides, LLC, Matthew E. Lipman and Michael Toporek, dated July 24, 2017.</FONT></TD></TR>
</TABLE>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; font-size: 10pt">CUSIP NO. 14068E109</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">After reasonable inquiry
and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement
is true, complete and correct.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp;July 24, 2017</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">BP Peptides, LLC</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Matthew E. Lipman</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 6%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 34%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Manager and President</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Matthew E. Lipman</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Michael Toporek</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Michael Toporek</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>2
<FILENAME>ex994to13d10959006_072417.htm
<DESCRIPTION>LETTER AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">Exhibit 99.4</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>BP
PEPTIDES, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">122 East 42nd Street, Suite 4305</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, New York 10168</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">July 14, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Biotechnology Value Fund, L.P.<BR>
Biotechnology Value Fund II, L.P.<BR>
Investment 10, L.L.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BVF MSI SPV, L.L.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BVF Investments, L.L.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">1 Sansome Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">San Francisco, California 94104<BR>
Attention: Mark N. Lampert</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD><B>Shares of Common Stock of Capstone Therapeutics Corp.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Dear Mark:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This letter is being delivered in connection
with the purchase from the entities listed on <U>Exhibit A</U> (each, individually, a &ldquo;<B>Seller</B>&rdquo; and collectively,
the &ldquo;<B>Sellers</B>&rdquo;) by BP Peptides, LLC (&ldquo;<B>Purchaser</B>&rdquo;) of the number of shares of common stock,
par value $0.0005 (the &ldquo;<B>Common Stock</B>&rdquo;), of Capstone Therapeutics Corp. (the &ldquo;<B>Company</B>&rdquo;) set
forth opposite each Seller&rsquo;s name on <U>Exhibit A</U> at a purchase price of $0.06 per share (such shares of Common Stock
being purchased hereunder, the &ldquo;<B>Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Subject to the terms and conditions of this letter agreement, at the Closing (as defined below) Sellers will sell, assign,
transfer and convey to Purchaser, and Purchaser will purchase, the Shares for an aggregate purchase price of $302,471.82 (the &ldquo;<B>Purchase
Price</B>&rdquo;). The purchase and sale of the Shares will take place remotely via the exchange of documents and signatures concurrently
with the closing of that certain Securities Purchase, Loan and Security Agreement (the &ldquo;<B>Capstone Agreement</B>&rdquo;),
dated the date hereof, by and between Purchaser and the Company (the &ldquo;<B>Closing</B>&rdquo;). At the Closing, Purchaser will
deliver the portion of the Purchase Price to each Seller by a wire transfer of immediately available funds in the amount and to
the account set forth opposite Seller&rsquo;s name on <U>Exhibit A</U> and Sellers will initiate the electronic delivery of the
Shares to Purchaser to the account set forth on <U>Exhibit B</U> upon receipt of such wire transfer. Also at the Closing, the Purchaser
will pay, or cause the Company to pay, the amounts due under the Notes, as contemplated under Section 6 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Each
Seller, with respect to itself only, hereby represents and warrants to Purchaser as of the Closing as follows: (i) each Seller
is duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization, (ii) each Seller
has all requisite power and authority to execute and deliver this letter agreement and to consummate the transactions described
herein, (iii) the execution and delivery by each Seller of this letter agreement and the performance by each Seller of its obligations
hereunder have been duly authorized by all requisite action on the part of Seller and no other proceedings on the part of Seller
are necessary to authorize the execution and delivery of this letter agreement and the consummation of the transactions contemplated
hereby, (iv) this letter agreement has been duly executed and delivered by each Seller and assuming due authorization, execution
and delivery of this letter agreement by Purchaser constitutes a valid and legally binding obligation of each Seller, enforceable
against Seller in accordance with its terms, except (y) as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, or other laws of general application relating to or affecting the enforcement of creditors&rsquo; rights
generally, or (z) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies, (v) each Seller owns, beneficially and/or of record, the Shares as set forth on <U>Exhibit A</U> and has good, valid
and marketable title to the Shares, free and clear of any and all covenants, conditions, restrictions, voting trust arrangements,
proxies, liens, charges, encumbrances, options and adverse claims or rights whatsoever (&ldquo;<B>Liens</B>&rdquo;), except for
restrictions on transfer arising under applicable federal and state securities laws, (vi) (y) the Internal Revenue Service (&ldquo;<B>IRS</B>&rdquo;)
Forms W-9 or (z) IRS Forms W-8BEN-E, IRS Forms W-8BEN or other applicable IRS Forms W-8 (including any IRS forms, documents or
schedules required to be attached thereto) delivered to Purchaser prior to the date hereof were properly completed and executed
by each Seller, (vii) at the Closing, each Seller will deliver to Purchaser good, valid and marketable title to its Shares, free
and clear of all Liens, except for restrictions on transfer arising under applicable federal and state securities laws, (viii)
the execution and delivery of this letter agreement and the performance by each Seller of its obligations hereunder will not (x)
violate or breach any provision of Seller&rsquo;s organizational or governing documents, (y) violate or breach any statute, law,
rule or regulation applicable to Seller or order applicable to Seller or by which Seller or any of its properties may be bound
or (z) breach, or result in a default under, any contract to which Seller is a party or by which Seller or any of its properties
may be bound, except in the case of clauses (y) and (z), where such violations, breaches and defaults would not affect Seller&rsquo;s
ability to execute, deliver and perform its obligations under this letter agreement in any material respect and (ix) there is no
action, lawsuit, arbitration, claim or proceeding pending or, to the knowledge of each Seller, threatened against Seller that would
reasonably be expected to impede the consummation of the transactions described herein.</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Each Seller, with respect to itself only, acknowledges that Purchaser has previously conducted negotiations with and due
diligence on the Company with respect to the Capstone Agreement and that Purchaser, Purchaser&rsquo;s affiliates (within the meaning
of Rule 405 promulgated under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;) (&ldquo;<B>Affiliates</B>&rdquo;)),
and Purchaser&rsquo;s and such Affiliates&rsquo; directors, officers, partners, stockholders, members, investors, employees, attorneys,
agents, representatives, as applicable, and successors and assigns thereto (collectively with Purchaser, the &ldquo;<B>Purchaser
Related Parties</B>&rdquo;), as a result of such prior activities, may possess and/or may have access to and/or may hereafter possess
and/or have access to certain non-public information concerning the Company and its Affiliates and/or the Common Stock (the &ldquo;<B>Non-Public
Information</B>&rdquo;) that may or may not be known by Seller which may constitute material information with respect to the foregoing,
and that Purchaser is relying on this letter agreement and would not enter into a transaction to purchase the Shares from Seller
absent this letter agreement. Each Seller agrees to sell its Shares to Purchaser notwithstanding that it is aware that such Non-Public
Information may exist, that Purchaser may not have disclosed to it any or all Non-Public Information that it may have in its possession,
and that Purchaser is making no representations regarding the existence or non-existence of such Non-Public Information and whether
such information (if any) has been disclosed to Sellers. Each Seller, with respect to itself only, acknowledges that it is an &ldquo;accredited
investor&rdquo; within the meaning of Rule 501(a)(1), (2), (3), (7) or (8) of Regulation D promulgated under the Securities Act
and a sophisticated seller with respect to the purchase and sale of securities such as the Shares and that Purchaser has no obligations
to Seller to disclose such Non-Public Information and that if the Non-Public Information were fully disclosed to Seller, the Non-Public
Information could potentially affect Seller&rsquo;s willingness to enter into this letter agreement and the price that Seller would
be willing to accept to sell the Shares. Moreover, such Non-Public Information may indicate that the value of the Shares is substantially
lower or higher than the Purchase Price. Additionally, each Seller, with respect to itself only, acknowledges that it has adequate
information concerning the Common Stock and the business and financial condition of the Company and its Affiliates to make an informed
decision regarding the sale of the Shares, and has independently and without reliance upon Purchaser, and based upon such information
as Seller has deemed appropriate, made its own analysis and decision to sell the Shares to Purchaser. Each Seller acknowledges,
with respect to itself only, that it is experienced, sophisticated and knowledgeable in the trading of securities and other instruments
of private and public companies and understands the disadvantage to which it may be subject on account of any disparity of the
access to, and possession of, such Non-Public Information between Seller and Purchaser. Each Seller acknowledges, with respect
to itself only, that it has conducted an independent evaluation of the Shares to determine whether to enter into this letter agreement
and, notwithstanding the absence of access by Seller to the Non-Public Information known by Purchaser, Seller is desirous of entering
into this letter agreement and consummating the transactions contemplated hereby. Each Seller acknowledges, with respect to itself
only, that because of, among other things, its business and financial experience, it is capable of evaluating the merits and risks
of the transactions contemplated by this letter agreement and of protecting its own interests in connection with this letter agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Purchaser hereby represents and warrants to Sellers as of the Closing as follows: (i) Purchaser is duly organized, validly
existing and in good standing under the laws of the jurisdiction of its organization, (ii) Purchaser has all requisite power and
authority to execute and deliver this letter agreement and to consummate the transactions described herein, (iii) the execution
and delivery by Purchaser of this letter agreement and the performance by Purchaser of its obligations hereunder have been duly
authorized by all requisite action on the part of Purchaser and no other proceedings on the part of Purchaser are necessary to
authorize the execution and delivery of this letter agreement and the consummation of the transactions contemplated hereby, (iv)
this letter agreement has been duly executed and delivered by Purchaser and assuming due authorization, execution and delivery
of this letter agreement by Sellers constitutes a valid and legally binding obligation of Purchaser, enforceable against Purchaser
in accordance with its terms, except (y) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, or other laws of general application relating to or affecting the enforcement of creditors&rsquo; rights generally,
or (z) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies,
and (v) the execution and delivery of this letter agreement and the performance by Purchaser of its obligations hereunder will
not (x) violate or breach any provision of Purchaser&rsquo;s organizational or governing documents, (y) violate or breach any statute,
law, rule or regulation applicable to Purchaser or order applicable to Purchaser or by which Purchaser or any of its properties
may be bound or (z) breach, or result in a default under, any contract to which Purchaser is a party or by which Purchaser or any
of its properties may be bound, except in the case of clauses (y) and (z), where such violations, breaches or defaults would not
affect Purchaser&rsquo;s ability to execute, deliver and perform its obligations under this letter agreement in any material respect
and (vi) there is no action, lawsuit, arbitration, claim or proceeding pending or, to the knowledge of Purchaser, threatened against
Purchaser that would reasonably be expected to impede the consummation of the transactions described herein.</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Purchaser acknowledges that Sellers are significant stockholders of the Company and that Sellers, Sellers&rsquo; Affiliates
and Sellers&rsquo; and such Affiliates&rsquo; directors, officers, partners, stockholders, members, investors, employees, attorneys,
agents, representatives, as applicable, and successors and assigns thereto (collectively with Sellers, the &ldquo;<B>Seller Related
Parties</B>&rdquo;) may possess and/or may have access to and/or may hereafter possess and/or have access to Non-Public Information
that may or may not be known by Purchaser which may constitute material information with respect to the foregoing, and that Sellers
are relying on this letter agreement and would not enter into a transaction to sell the Shares to Purchaser absent this letter
agreement. Purchaser agrees to purchase Sellers&rsquo; Shares from Sellers notwithstanding that it is aware that such Non-Public
Information may exist, that Sellers may not have disclosed any or all Non-Public Information to it, and that Sellers are making
no representations regarding the existence or non-existence of such Non-Public Information and whether such information (if any)
has been disclosed to Purchaser. Purchaser acknowledges that it is an &ldquo;accredited investor&rdquo; within the meaning of Rule
501(a)(1), (2), (3) (7) or (8) of Regulation D promulgated under the Securities Act. Purchaser acknowledges that it is a sophisticated
purchaser with respect to the purchase and sale of securities such as the Shares and that Sellers have no obligations to Purchaser
to disclose such Non-Public Information and that if the Non-Public Information were fully disclosed to Purchaser, the Non-Public
Information could potentially affect Purchaser&rsquo;s willingness to enter into this letter agreement and the price that Purchaser
would be willing to pay to purchase the Shares. Moreover, such Non-Public Information may indicate that the value of the Shares
is substantially lower or higher than the Purchase Price. Additionally, Purchaser acknowledges that it has adequate information
concerning the Common Stock and the business and financial condition of the Company and its Affiliates to make an informed decision
regarding the purchase of the Shares, and has independently and without reliance upon Sellers, and based upon such information
as Purchaser has deemed appropriate, made its own analysis and decision to purchase the Shares from Sellers. Purchaser is experienced,
sophisticated and knowledgeable in the trading of securities and other instruments of private and public companies and understands
the disadvantage to which it may be subject on account of any disparity of the access to, and possession of, such Non-Public Information
between Purchaser and Sellers. Purchaser has conducted an independent evaluation of the Shares to determine whether to enter into
this letter agreement and, notwithstanding the absence of access by Purchaser to the Non-Public Information known by Sellers, Purchaser
is desirous of entering into this letter agreement and consummating the transactions contemplated hereby. Purchaser, because of,
among other things, its business and financial experience, is capable of evaluating the merits and risks of the transactions contemplated
by this letter agreement and of protecting its own interests in connection with this letter agreement.</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Purchaser acknowledges and agrees that concurrently with the Closing, a portion of the proceeds the Company is entitled
to receive in connection with the transactions contemplated by the Capstone Agreement will be used to satisfy in full all outstanding
indebtedness under those certain Convertible Promissory Notes, dated December 11, 2015, listed on <U>Exhibit C</U> (the &ldquo;<B>Notes</B>&rdquo;)
in accordance with the terms of the Capstone Agreement. The parties agree that as of the Closing, the total outstanding indebtedness
under the Notes is $1,079,041.09. The obligation to repay the Notes as set forth in this Section 6 is a material inducement to
cause the Sellers to sell the Shares. Accordingly, the failure to timely repay such indebtedness in full shall constitute a material
breach of this Agreement and shall give rise to any applicable rights and remedies on the part of the Sellers, including (without
limitation) the right to rescind the sale of the Shares hereunder. Sellers agree that concurrently with the Closing and the payment
in full of all outstanding indebtedness under the Notes in accordance with this Section 6, Sellers&rsquo; blanket lien on and security
interest in the Company&rsquo;s tangible and intangible assets securing all indebtedness under the Notes shall be deemed terminated
and released and, in furtherance of the foregoing, concurrently with the Closing, Sellers shall file UCC termination statements
on Form UCC-3 and any other instruments reasonably requested by the Purchaser acknowledging such termination and release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>For a period of three (3) years from the date hereof, Sellers and their Affiliates will not, without the prior written consent
of Purchaser and the Company: (i) acquire, offer to acquire, or agree to acquire directly or indirectly, by purchase or otherwise,
record, beneficial or other ownership of any additional shares of Common Stock, any convertible, derivative or other securities
of the Company or rights to acquire any such securities, or enter into, offer to enter into, or agree to enter into, directly or
indirectly, any Derivatives Contract (as defined below), except pursuant to a stock split, recapitalization, stock dividend or
other similar transaction by the Company, (ii) effect or seek, offer or propose (whether publicly or otherwise) to effect, or announce
any intention to effect or cause or participate in or in any way assist, facilitate or encourage any other person to effect or
seek, offer or propose (whether publicly or otherwise) to effect or participate in, (a) any acquisition of any assets, indebtedness
or businesses of the Company or any of its subsidiaries or Affiliates, (b) any tender or exchange offer, merger or other business
combination involving the Company or any of its subsidiaries or Affiliates or assets of the Company or its subsidiaries or Affiliates
constituting a significant portion of the consolidated assets of the Company and its subsidiaries or Affiliates, (c) any recapitalization,
restructuring, liquidation, dissolution or other extraordinary transaction with respect to the Company or any of its subsidiaries
or Affiliates, or (d) any nomination of directors for election to the Board of Directors of the Company, (iii) form, join or in
any way participate in a &ldquo;group&rdquo; (as defined under the Securities Exchange Act of 1934, as amended) with respect to
the Company (other than the existing &ldquo;group&rdquo; comprised of Sellers and their Affiliates with respect to the Company)
or otherwise act in concert with any person in respect of any such securities, (iv) otherwise act, alone or in concert with others,
to seek representation on or to control or influence the management, Board of Directors or policies of the Company, (v) take any
action which would or would reasonably be expected to force the Company to make a public announcement regarding any of the types
of matters set forth above, or (vi) enter into any discussions or arrangements with any third party with respect to any of the
foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0in">For purposes of this letter agreement,
&ldquo;Derivatives Contract&rdquo; means a contract between two parties (the &ldquo;<B>Receiving Party</B>&rdquo; and the &ldquo;<B>Counterparty</B>&rdquo;)
that is designed to produce economic benefits and risks to the Receiving Party that correspond substantially to the ownership by
the Receiving Party of a number of shares of Common Stock or other Company securities specified or referenced in such contract,
regardless of whether (i) obligations under such contract are required or permitted to be settled through the delivery of cash,
shares of Common Stock or other securities or property or (ii) such contract conveys any voting rights in shares of Common Stock
or other securities, without regard to any short or similar position under the same or any other Derivatives Contract.</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Each Seller does for itself only and its respective successors and/or assigns, hereby to the maximum extent permitted by
law irrevocably forever releases, discharges and waives any and all claims, rights, causes of action, suits, obligations, debts,
demands, liabilities, controversies, costs, expenses, fees, or damages of any kind (including, but not limited to, any and all
claims alleging violations of federal or state securities laws, common-law fraud or deceit, breach of fiduciary duty, negligence
or otherwise), whether directly, derivatively, representatively or in any other capacity, against the Company and the Purchaser
Related Parties, arising on or prior to the date hereof, which are based upon, arise from or in any way relate to or involve, directly
or indirectly, Purchaser&rsquo;s failure to disclose all or any portion of the Non-Public Information known by it to Seller in
connection with the transfer of the Shares by Seller to Purchaser. Each Seller, with respect to itself only, also agrees that it
shall not institute or maintain any cause of action, suit, complaint or other proceeding against the Company or any of the Purchaser
Related Parties as a result of Purchaser&rsquo;s failure to disclose fully such Non-Public Information to Seller or otherwise in
connection with this letter agreement. Each Seller, with respect to itself only, also represents that it has not assigned any claim
or possible claim against the Company or the Purchaser Related Parties that relates to the Non-Public Information, it fully intends
to release all claims against the Company and the Purchaser Related Parties that related to the Non-Public Information as set forth
above and it has been advised by, and has consulted with counsel with respect to the execution and delivery of this letter agreement
and has been fully apprised of the consequences of the waivers, releases and discharges set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Purchaser does for itself and its respective successors and/or assigns, hereby to the maximum extent permitted by law irrevocably
forever releases, discharges and waives any and all claims, rights, causes of action, suits, obligations, debts, demands, liabilities,
controversies, costs, expenses, fees, or damages of any kind (including, but not limited to, any and all claims alleging violations
of federal or state securities laws, common-law fraud or deceit, breach of fiduciary duty, negligence or otherwise), whether directly,
derivatively, representatively or in any other capacity, against the Company and the Seller Related Parties, arising on or prior
to the date hereof, which are based upon, arise from or in any way relate to or involve, directly or indirectly, Sellers&rsquo;
failure to disclose all or any portion of the Non-Public Information known by them to Purchaser in connection with the transfer
of the Shares by Sellers to Purchaser. Purchaser also agrees that it shall not institute or maintain any cause of action, suit,
complaint or other proceeding against any of the Company or the Seller Related Parties as a result of Sellers&rsquo; failure to
disclose fully such Non-Public Information to Purchaser or otherwise in connection with this letter agreement. Purchaser also represents
that it has not assigned any claim or possible claim against the Company or the Seller Related Parties that relates to the Non-Public
Information, it fully intends to release all claims against the Company and the Seller Related Parties that related to the Non-Public
Information as set forth above and it has been advised by, and has consulted with counsel with respect to the execution and delivery
of this letter agreement and has been fully apprised of the consequences of the waivers, releases and discharges set forth herein.</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

</FONT>Each Seller and Purchaser agrees that this letter agreement, including, without limitation, the representations, warranties,
agreements, waivers, releases, acceptances and acknowledgments contained herein, shall be binding upon and inure to the benefit
of Purchaser and each Seller and their respective successors and assigns, and shall survive the execution and delivery of this
letter agreement and the consummation of the sale of Sellers&rsquo; Shares to Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This letter agreement constitutes the entire agreement between the parties, supersedes any prior agreements and understandings,
written or oral, between the parties with respect to the subject matter of this letter agreement, and contains the only representations
or warranties on which the parties are entitled to rely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All questions concerning the construction, validity, enforcement and interpretation of this letter agreement shall be governed
by the internal laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule
(whether of the State of Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of Delaware. Each party hereby irrevocably submits to the exclusive jurisdiction of the United States District
Court for the District of Delaware located in New Castle County, or, if jurisdiction in such court is not available, any state
court located in New Castle County in the State of Delaware, for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any
suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit,
action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each
party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof to such party at its address set forth herein and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST,
A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION
CONTEMPLATED HEREBY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>This letter agreement may be executed in counterparts.&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Please indicate your acknowledgment and agreement
to the foregoing by signing below where indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">PURCHASER:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="text-transform: uppercase">bp pEPTIDES, LLC</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt">/s/ Matthew E. Lipman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 13%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt">Name:</TD>
    <TD STYLE="width: 67%; padding-right: 5.75pt; padding-left: 5.75pt">Matthew E. Lipman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Title:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Manager and President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><B>ACKNOWLEDGED AND AGREED<BR>
    AS OF THE DATE FIRST WRITTEN ABOVE:</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">SELLERS:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BIOTECHNOLOGY VALUE FUND, L.P.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="width: 88%; padding-right: 5.75pt; padding-left: 5.75pt">BVF Partners L.P., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BVF Inc., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Mark N. Lampert</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Mark N. Lampert</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BIOTECHNOLOGY VALUE FUND II, L.P.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="width: 88%; padding-right: 5.75pt; padding-left: 5.75pt">BVF Partners L.P., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BVF Inc., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Mark N. Lampert</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Mark N. Lampert</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">INVESTMENT 10, L.L.C.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="width: 88%; padding-right: 5.75pt; padding-left: 5.75pt">BVF Partners L.P., its manager</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BVF, Inc., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Mark N. Lampert</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Mark N. Lampert</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">MSI BVF SPV, L.L.C.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="width: 88%; padding-right: 5.75pt; padding-left: 5.75pt">BVF Partners L.P., its manager</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BVF, Inc., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Mark N. Lampert</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Mark N. Lampert</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BVF INVESTMENTS, L.L.C.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 12%; padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="width: 88%; padding-right: 5.75pt; padding-left: 5.75pt">BVF Partners L.P., its manager</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">BVF Inc., its general partner</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">By:</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Mark N. Lampert</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">Mark N. Lampert</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">President</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: center"><TD STYLE="width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Exhibit A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Sellers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; border: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Name</B></TD>
    <TD STYLE="width: 33%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Shares to be Sold</B></TD>
    <TD STYLE="width: 33%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Total Purchase Price</B></TD>
    </TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Biotechnology Value Fund, L.P.&nbsp;</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">242,236</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$14,534.16</TD>
    </TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Biotechnology Value Fund II, L.P.&nbsp;</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">105,713</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$6,342.78</TD>
    </TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Investment 10, L.L.C.</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">377,115</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$22,626.90</TD>
    </TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">BVF MSI SPV, L.L.C.</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">322,496</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$19,349.76</TD>
    </TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">BVF Investments, L.L.C.&nbsp;</P></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">3,993,637</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">$239,618.22</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Exhibit B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Purchase Account Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>DTC Instructions</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><BR CLEAR="ALL">
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Exhibit C</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Convertible Promissory Notes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<UL STYLE="margin-top: 0in; list-style-type: disc">

<LI STYLE="margin: 0">Convertible Promissory Note, dated December 11, 2015, payable to Biotechnology Value Fund, L.P.</LI>

</UL>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<UL STYLE="margin-top: 0in; list-style-type: disc">

<LI STYLE="margin: 0">Convertible Promissory Note, dated December 11, 2015, payable to Biotechnology Value Fund II, L.P.</LI>

</UL>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<UL STYLE="margin-top: 0in; list-style-type: disc">

<LI STYLE="margin: 0">Convertible Promissory Note, dated December 11, 2015, payable to Biotechnology Value Trading Fund OS, L.P.</LI>

</UL>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<UL STYLE="margin-top: 0in; list-style-type: disc">

<LI STYLE="margin: 0">Convertible Promissory Note, dated December 11, 2015, payable to Investment 10, LLC.</LI>

</UL>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<UL STYLE="margin-top: 0in; list-style-type: disc">

<LI STYLE="margin: 0">Convertible Promissory Note, dated December 11, 2015, payable to MSI BVF SPV, LLC.</LI>

</UL>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.5
<SEQUENCE>3
<FILENAME>ex995to13d10959006_072417.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">Exhibit 99.5</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">JOINT FILING AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">In accordance with
Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing
on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, $0.0005
par value per share, of Capstone Therapeutics Corp. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Dated:&nbsp;&nbsp;July 24, 2017</FONT></TD>
    <TD COLSPAN="3" STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">BP Peptides, LLC</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Matthew E. Lipman</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 6%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 9%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 34%; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Manager and President</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; width: 51%">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; width: 49%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Matthew E. Lipman</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 51%; padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-right: 5.75pt; padding-left: 5.75pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ Michael Toporek</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-size: 10pt">Michael Toporek</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
